SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-048035
Filing Date
2022-08-15
Accepted
2022-08-15 16:09:42
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_aditxtinc.htm   iXBRL 10-Q 707936
2 CERTIFICATION f10q0622ex31-1_aditxtinc.htm EX-31.1 9662
3 CERTIFICATION f10q0622ex31-2_aditxtinc.htm EX-31.2 9521
4 CERTIFICATION f10q0622ex32-1_aditxtinc.htm EX-32.1 4531
  Complete submission text file 0001213900-22-048035.txt   4134861

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20220630.xsd EX-101.SCH 60254
6 XBRL CALCULATION FILE adtx-20220630_cal.xml EX-101.CAL 28052
7 XBRL DEFINITION FILE adtx-20220630_def.xml EX-101.DEF 211213
8 XBRL LABEL FILE adtx-20220630_lab.xml EX-101.LAB 487367
9 XBRL PRESENTATION FILE adtx-20220630_pre.xml EX-101.PRE 222983
52 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_aditxtinc_htm.xml XML 399798
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39336 | Film No.: 221165719
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences